3315F Er+ or pr+ breast cancer
Other
Also known as: ER positive breast cancer, PR positive status, hormone receptor positive
Performance measure documenting estrogen receptor positive or progesterone receptor positive breast cancer. Quality metric for hormone receptor status determination.
Clinical Context
Quality measure documenting hormone receptor status essential for predicting response to endocrine therapy and guiding treatment selection in breast cancer.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.